Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives

Cancers (Basel). 2022 May 11;14(10):2371. doi: 10.3390/cancers14102371.

Abstract

Skin cancer is one of the main types of cancer worldwide, and non-melanoma skin cancer (NMSC) is the most frequent within this group. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common types. Multifactorial features are well-known for cancer development, and new hallmarks are gaining relevance. Genetics and epigenetic regulation play an essential role in cancer susceptibility and progression, as well as the variety of cells and molecules that interact in the tumor microenvironment. In this review, we provide an update on the genetic features of NMSC, candidate genes, and new therapies, considering diverse perspectives of skin carcinogenesis. The global health situation and the pandemic have been challenging for health care systems, especially in the diagnosis and treatment of patients with cancer. We provide innovative approaches to overcome the difficulties in the current clinical dynamics.

Keywords: NMSC genetics; UVB radiation; basal cell carcinoma; epigenetics; immunotherapy; non-melanoma skin cancer; skin cancer; squamous cell carcinoma; tumor microenvironment.

Publication types

  • Review

Grants and funding

The APC was funded by APPAC IV CUCS-UDG 2022.